Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

John McCorvy PhD

John McCorvy PhD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Cell Biology, Neurobiology and Anatomy
Program: Administration

Member of the Cancer Center
Member of the Neuroscience Research Center


I am willing to collaborate on research projects.

View Curriculum Vitae

Research Experience

  • Antipsychotic Agents
  • Binding Sites
  • Central Nervous System Stimulants
  • Crystallography, X-Ray
  • Dopamine Agonists
  • Drug Design
  • Drug Discovery
  • Hallucinogens
  • Kinetics
  • Ligands
  • Lysergic Acid Diethylamide
  • Models, Molecular
  • Molecular Structure
  • Mutation
  • Piperazines
  • Protein Binding
  • Protein Conformation
  • Protein Structure, Secondary
  • Receptor, Melatonin, MT1
  • Receptor, Serotonin, 5-HT2B
  • Receptor, Serotonin, 5-HT2C
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Receptors, G-Protein-Coupled
  • Schizophrenia
  • Serotonin 5-HT2 Receptor Agonists
  • Signal Transduction
  • Structure-Activity Relationship
  • beta-Arrestins

    • Publications (71)

  • Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential. (Wallach J, Cao AB, Calkins MM, Heim AJ, Lanham JK, Bonniwell EM, Hennessey JJ, Bock HA, Anderson EI, Sherwood AM, Morris H, de Klein R, Klein AK, Cuccurazzu B, Gamrat J, Fannana T, Zauhar R, Halberstadt AL, McCorvy JD) Nat Commun 2023 Dec 15;14(1):8221 PMID: 38102107 PMCID: PMC10724237 SCOPUS ID: 2-s2.0-85179903706 12/16/2023       7 Citations
  • Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism. (Rodriguez P, Laskowski LJ, Pallais JP, Bock HA, Cavalco NG, Anderson EI, Calkins MM, Razzoli M, Sham YY, McCorvy JD, Bartolomucci A) J Biol Chem 2024 Jan;300(1):105549 PMID: 38072064 PMCID: PMC10796979 SCOPUS ID: 2-s2.0-85181819143 12/11/2023    
  • Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action. (Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A) J Neurosci 2023 Nov 08;43(45):7472-7482 PMID: 37940583 PMCID: PMC10634557 SCOPUS ID: 2-s2.0-85176431720 11/09/2023       3 Citations
  • Structure activity relationships of 5-HT2B and 5-HT2C serotonin receptor antagonists: N6, C2 and 5′-Modified (N)-methanocarba-adenosine derivatives (Tosh DK, Calkins MM, Ivancich MS, Bock HA, Campbell RG, Lewicki SA, Chen E, Gao ZG, McCorvy JD, Jacobson KA) European Journal of Medicinal Chemistry 5 November 2023;259 SCOPUS ID: 2-s2.0-85166945754 11/05/2023       1 Citation
  • Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala. (Kelly TJ, Bonniwell EM, Mu L, Liu X, Hu Y, Friedman V, Yu H, Su W, McCorvy JD, Liu QS) Neuropsychopharmacology 2024 Apr;49(5):854-863 PMID: 37752222 PMCID: PMC10948882 SCOPUS ID: 2-s2.0-85172244117 09/27/2023       3 Citations
  • Molecular insights into GPCR mechanisms for drugs of abuse. (Sanchez-Reyes OB, Zilberg G, McCorvy JD, Wacker D) J Biol Chem 2023 Sep;299(9):105176 PMID: 37599003 PMCID: PMC10514560 SCOPUS ID: 2-s2.0-85171147748 08/21/2023       1 Citation
  • Structure activity relationships of 5-HT2B and 5-HT2C serotonin receptor antagonists: N6, C2 and 5'-Modified (N)-methanocarba-adenosine derivatives. (Tosh DK, Calkins MM, Ivancich MS, Bock HA, Campbell RG, Lewicki SA, Chen E, Gao ZG, McCorvy JD, Jacobson KA) Eur J Med Chem 2023 Nov 05;259:115691 PMID: 37562117 PMCID: PMC10529765 SCOPUS ID: 2-s2.0-85166945754 08/11/2023       1 Citation
  • Angiotensin AT1A receptor signal switching in Agouti-related peptide neurons mediates metabolic rate adaptation during obesity. (Balapattabi K, Yavuz Y, Jiang J, Deng G, Mathieu NM, Ritter ML, Opichka MA, Reho JJ, McCorvy JD, Nakagawa P, Morselli LL, Mouradian GC Jr, Atasoy D, Cui H, Hodges MR, Sigmund CD, Grobe JL) Cell Rep 2023 Aug 29;42(8):112935 PMID: 37540598 PMCID: PMC10530419 SCOPUS ID: 2-s2.0-85169503465 08/04/2023       1 Citation
  • Mu-opioid receptor selective superagonists produce prolonged respiratory depression. (Malcolm NJ, Palkovic B, Sprague DJ, Calkins MM, Lanham JK, Halberstadt AL, Stucke AG, McCorvy JD) iScience 2023 Jul 21;26(7):107121 PMID: 37416459 PMCID: PMC10320493 SCOPUS ID: 2-s2.0-85163518147 07/07/2023       8 Citations
  • A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. (Lewis V, Bonniwell EM, Lanham JK, Ghaffari A, Sheshbaradaran H, Cao AB, Calkins MM, Bautista-Carro MA, Arsenault E, Telfer A, Taghavi-Abkuh FF, Malcolm NJ, El Sayegh F, Abizaid A, Schmid Y, Morton K, Halberstadt AL, Aguilar-Valles A, McCorvy JD) Cell Rep 2023 Mar 28;42(3):112203 PMID: 36884348 PMCID: PMC10112881 SCOPUS ID: 2-s2.0-85149448597 03/09/2023       24 Citations
  • Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. (Vargas MV, Dunlap LE, Dong C, Carter SJ, Tombari RJ, Jami SA, Cameron LP, Patel SD, Hennessey JJ, Saeger HN, McCorvy JD, Gray JA, Tian L, Olson DE) Science 2023 Feb 17;379(6633):700-706 PMID: 36795823 PMCID: PMC10108900 SCOPUS ID: 2-s2.0-85148258353 02/17/2023       82 Citations
  • DPP4-Truncated CXCL12 Alters CXCR4/ACKR3 Signaling, Osteogenic Cell Differentiation, Migration, and Senescence. (Elmansi AM, Eisa NH, Periyasamy-Thandavan S, Kondrikova G, Kondrikov D, Calkins MM, Aguilar-Pérez A, Chen J, Johnson M, Shi XM, Reitman C, McGee-Lawrence ME, Crawford KS, Dwinell MB, Volkman BF, Blumer JB, Luttrell LM, McCorvy JD, Hill WD) ACS Pharmacol Transl Sci 2023 Jan 13;6(1):22-39 PMID: 36659961 PMCID: PMC9844133 SCOPUS ID: 2-s2.0-85143982229 01/21/2023       1 Citation
  • Molecular and cellular basis of praziquantel action in the cardiovascular system. (Yahya NA, Lanham JK, Sprague DJ, Palygin O, McCorvy JD, Marchant JS) Am J Physiol Cell Physiol 2023 Feb 01;324(2):C573-C587 PMID: 36622066 PMCID: PMC9942900 SCOPUS ID: 2-s2.0-85148113561 01/10/2023       3 Citations
  • Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs. (Cunningham MJ, Bock HA, Serrano IC, Bechand B, Vidyadhara DJ, Bonniwell EM, Lankri D, Duggan P, Nazarova AL, Cao AB, Calkins MM, Khirsariya P, Hwu C, Katritch V, Chandra SS, McCorvy JD, Sames D) ACS Chem Neurosci 2023 Jan 04;14(1):119-135 PMID: 36521179 PMCID: PMC10147382 SCOPUS ID: 2-s2.0-85144247830 12/16/2022       18 Citations
  • Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity. (Kaplan AL, Confair DN, Kim K, Barros-Álvarez X, Rodriguiz RM, Yang Y, Kweon OS, Che T, McCorvy JD, Kamber DN, Phelan JP, Martins LC, Pogorelov VM, DiBerto JF, Slocum ST, Huang XP, Kumar JM, Robertson MJ, Panova O, Seven AB, Wetsel AQ, Wetsel WC, Irwin JJ, Skiniotis G, Shoichet BK, Roth BL, Ellman JA) Nature 2022 Oct;610(7932):582-591 PMID: 36171289 PMCID: PMC9996387 SCOPUS ID: 2-s2.0-85139098126 09/29/2022       85 Citations
  • Characterization of Dual-Acting A3 Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gαi3 and GαoA Isoprotein Activation. (Fisher CL, Fallot LB, Wan TC, Keyes RF, Suresh RR, Rothwell AC, Gao ZG, McCorvy JD, Smith BC, Jacobson KA, Auchampach JA) ACS Pharmacol Transl Sci 2022 Aug 12;5(8):625-641 PMID: 35983277 PMCID: PMC9380209 SCOPUS ID: 2-s2.0-85135593508 08/20/2022       8 Citations
  • Conformational selection guides β-arrestin recruitment at a biased G protein-coupled receptor. (Kleist AB, Jenjak S, Sente A, Laskowski LJ, Szpakowska M, Calkins MM, Anderson EI, McNally LM, Heukers R, Bobkov V, Peterson FC, Thomas MA, Chevigné A, Smit MJ, McCorvy JD, Babu MM, Volkman BF) Science 2022 Jul 08;377(6602):222-228 PMID: 35857540 PMCID: PMC9574477 SCOPUS ID: 2-s2.0-85133822505 07/21/2022       13 Citations
  • Discovery of Highly Potent Serotonin 5-HT2 Receptor Agonists Inspired by Heteroyohimbine Natural Products. (Orr MJ, Cao AB, Wang CT, Gaisin A, Csakai A, Friswold AP, Meltzer HY, McCorvy JD, Scheidt KA) ACS Med Chem Lett 2022 Apr 14;13(4):648-657 PMID: 35450369 PMCID: PMC9014500 SCOPUS ID: 2-s2.0-85127900703 04/23/2022       3 Citations
  • Structure, function and pharmacology of human itch GPCRs. (Cao C, Kang HJ, Singh I, Chen H, Zhang C, Ye W, Hayes BW, Liu J, Gumpper RH, Bender BJ, Slocum ST, Krumm BE, Lansu K, McCorvy JD, Kroeze WK, English JG, DiBerto JF, Olsen RHJ, Huang XP, Zhang S, Liu Y, Kim K, Karpiak J, Jan LY, Abraham SN, Jin J, Shoichet BK, Fay JF, Roth BL) Nature 2021 Dec;600(7887):170-175 PMID: 34789874 PMCID: PMC9150435 SCOPUS ID: 2-s2.0-85119397373 11/19/2021       93 Citations
  • (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice. (Rudin D, McCorvy JD, Glatfelter GC, Luethi D, Szöllősi D, Ljubišić T, Kavanagh PV, Dowling G, Holy M, Jaentsch K, Walther D, Brandt SD, Stockner T, Baumann MH, Halberstadt AL, Sitte HH) Neuropsychopharmacology 2022 Mar;47(4):914-923 PMID: 34750565 PMCID: PMC8882185 SCOPUS ID: 2-s2.0-85118628713 11/10/2021       9 Citations
  • Transient receptor potential canonical 5 mediates inflammatory mechanical and spontaneous pain in mice. (Sadler KE, Moehring F, Shiers SI, Laskowski LJ, Mikesell AR, Plautz ZR, Brezinski AN, Mecca CM, Dussor G, Price TJ, McCorvy JD, Stucky CL) Sci Transl Med 2021 May 26;13(595) PMID: 34039739 PMCID: PMC8923002 SCOPUS ID: 2-s2.0-85106954302 05/28/2021       41 Citations
  • Investigation of the Structure-Activity Relationships of Psilocybin Analogues. (Klein AK, Chatha M, Laskowski LJ, Anderson EI, Brandt SD, Chapman SJ, McCorvy JD, Halberstadt AL) ACS Pharmacol Transl Sci 2021 Apr 09;4(2):533-542 PMID: 33860183 PMCID: PMC8033608 SCOPUS ID: 2-s2.0-85098963830 04/17/2021       49 Citations
  • A non-hallucinogenic psychedelic analogue with therapeutic potential. (Cameron LP, Tombari RJ, Lu J, Pell AJ, Hurley ZQ, Ehinger Y, Vargas MV, McCarroll MN, Taylor JC, Myers-Turnbull D, Liu T, Yaghoobi B, Laskowski LJ, Anderson EI, Zhang G, Viswanathan J, Brown BM, Tjia M, Dunlap LE, Rabow ZT, Fiehn O, Wulff H, McCorvy JD, Lein PJ, Kokel D, Ron D, Peters J, Zuo Y, Olson DE) Nature 2021 Jan;589(7842):474-479 PMID: 33299186 PMCID: PMC7874389 SCOPUS ID: 2-s2.0-85097312071 12/11/2020       188 Citations
  • The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3. (Wedemeyer MJ, Mahn SA, Getschman AE, Crawford KS, Peterson FC, Marchese A, McCorvy JD, Volkman BF) J Biol Chem 2020 Oct 02;295(40):13927-13939 PMID: 32788219 PMCID: PMC7535910 SCOPUS ID: 2-s2.0-85092681956 08/14/2020       6 Citations
  • TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. (Olsen RHJ, DiBerto JF, English JG, Glaudin AM, Krumm BE, Slocum ST, Che T, Gavin AC, McCorvy JD, Roth BL, Strachan RT) Nat Chem Biol 2020 Aug;16(8):841-849 PMID: 32367019 PMCID: PMC7648517 SCOPUS ID: 2-s2.0-85085073530 05/06/2020       241 Citations
  • Structure-based discovery of potent and selective melatonin receptor agonists. (Patel N, Huang XP, Grandner JM, Johansson LC, Stauch B, McCorvy JD, Liu Y, Roth B, Katritch V) Elife 2020 Mar 02;9 PMID: 32118583 PMCID: PMC7080406 SCOPUS ID: 2-s2.0-85082095283 03/03/2020       25 Citations
  • Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin. (Sherwood AM, Halberstadt AL, Klein AK, McCorvy JD, Kaylo KW, Kargbo RB, Meisenheimer P) J Nat Prod 2020 Feb 28;83(2):461-467 PMID: 32077284 SCOPUS ID: 2-s2.0-85080029383 02/23/2020       45 Citations
  • Virtual discovery of melatonin receptor ligands to modulate circadian rhythms. (Stein RM, Kang HJ, McCorvy JD, Glatfelter GC, Jones AJ, Che T, Slocum S, Huang XP, Savych O, Moroz YS, Stauch B, Johansson LC, Cherezov V, Kenakin T, Irwin JJ, Shoichet BK, Roth BL, Dubocovich ML) Nature 2020 Mar;579(7800):609-614 PMID: 32040955 PMCID: PMC7134359 SCOPUS ID: 2-s2.0-85082178883 02/11/2020       170 Citations
  • Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD). (Halberstadt AL, Chatha M, Klein AK, McCorvy JD, Meyer MR, Wagmann L, Stratford A, Brandt SD) Neuropharmacology 2020 Aug 01;172:107856 PMID: 31756337 PMCID: PMC9191647 SCOPUS ID: 2-s2.0-85076826541 11/23/2019       21 Citations
  • Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21. (Sahu BS, Rodriguez P, Nguyen ME, Han R, Cero C, Razzoli M, Piaggi P, Laskowski LJ, Pavlicev M, Muglia L, Mahata SK, O'Grady S, McCorvy JD, Baier LJ, Sham YY, Bartolomucci A) Cell Rep 2019 Sep 03;28(10):2567-2580.e6 PMID: 31484069 PMCID: PMC6753381 SCOPUS ID: 2-s2.0-85071223181 09/05/2019       18 Citations
  • Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT2C) receptor agonist without 5-HT2B agonism. (Zhang G, McCorvy JD, Shen S, Cheng J, Roth BL, Kozikowski AP) Eur J Med Chem 2019 Nov 15;182:111626 PMID: 31445232 PMCID: PMC6815260 SCOPUS ID: 2-s2.0-85070920510 08/25/2019       3 Citations
  • Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity. (Martini ML, Ray C, Yu X, Liu J, Pogorelov VM, Wetsel WC, Huang XP, McCorvy JD, Caron MG, Jin J) ACS Chem Neurosci 2019 Sep 18;10(9):4160-4182 PMID: 31387346 PMCID: PMC6785188 SCOPUS ID: 2-s2.0-85071950767 08/08/2019       18 Citations
  • Structural basis of ligand recognition at the human MT1 melatonin receptor. (Stauch B, Johansson LC, McCorvy JD, Patel N, Han GW, Huang XP, Gati C, Batyuk A, Slocum ST, Ishchenko A, Brehm W, White TA, Michaelian N, Madsen C, Zhu L, Grant TD, Grandner JM, Shiriaeva A, Olsen RHJ, Tribo AR, Yous S, Stevens RC, Weierstall U, Katritch V, Roth BL, Liu W, Cherezov V) Nature 2019 May;569(7755):284-288 PMID: 31019306 PMCID: PMC6696938 SCOPUS ID: 2-s2.0-85064887125 04/26/2019       144 Citations
  • XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity. (Johansson LC, Stauch B, McCorvy JD, Han GW, Patel N, Huang XP, Batyuk A, Gati C, Slocum ST, Li C, Grandner JM, Hao S, Olsen RHJ, Tribo AR, Zaare S, Zhu L, Zatsepin NA, Weierstall U, Yous S, Stevens RC, Liu W, Roth BL, Katritch V, Cherezov V) Nature 2019 May;569(7755):289-292 PMID: 31019305 PMCID: PMC6589158 SCOPUS ID: 2-s2.0-85064930899 04/26/2019       108 Citations
  • D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine. (Shen Y, McCorvy JD, Martini ML, Rodriguiz RM, Pogorelov VM, Ward KM, Wetsel WC, Liu J, Roth BL, Jin J) J Med Chem 2019 May 09;62(9):4755-4771 PMID: 30964661 PMCID: PMC6509010 SCOPUS ID: 2-s2.0-85065070718 04/10/2019       15 Citations
  • Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists. (Martini ML, Liu J, Ray C, Yu X, Huang XP, Urs A, Urs N, McCorvy JD, Caron MG, Roth BL, Jin J) J Med Chem 2019 Apr 11;62(7):3753-3772 PMID: 30875219 PMCID: PMC6688508 SCOPUS ID: 2-s2.0-85064197112 03/16/2019       14 Citations
  • Structural determinants of 5-HT2B receptor activation and biased agonism. (McCorvy JD, Wacker D, Wang S, Agegnehu B, Liu J, Lansu K, Tribo AR, Olsen RHJ, Che T, Jin J, Roth BL) Nat Struct Mol Biol 2018 Sep;25(9):787-796 PMID: 30127358 PMCID: PMC6237183 SCOPUS ID: 2-s2.0-85052592263 08/22/2018       93 Citations
  • Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. (Tan L, Yan W, McCorvy JD, Cheng J) J Med Chem 2018 Nov 21;61(22):9841-9878 PMID: 29939744 SCOPUS ID: 2-s2.0-85049218486 06/26/2018       86 Citations
  • High-throughput identification of G protein-coupled receptor modulators through affinity mass spectrometry screening. (Qin S, Meng M, Yang D, Bai W, Lu Y, Peng Y, Song G, Wu Y, Zhou Q, Zhao S, Huang X, McCorvy JD, Cai X, Dai A, Roth BL, Hanson MA, Liu ZJ, Wang MW, Stevens RC, Shui W) Chem Sci 2018 Mar 28;9(12):3192-3199 PMID: 29732102 PMCID: PMC5916221 SCOPUS ID: 2-s2.0-85044408356 05/08/2018       31 Citations
  • 5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology. (Peng Y, McCorvy JD, Harpsøe K, Lansu K, Yuan S, Popov P, Qu L, Pu M, Che T, Nikolajsen LF, Huang XP, Wu Y, Shen L, Bjørn-Yoshimoto WE, Ding K, Wacker D, Han GW, Cheng J, Katritch V, Jensen AA, Hanson MA, Zhao S, Gloriam DE, Roth BL, Stevens RC, Liu ZJ) Cell 2018 Feb 08;172(4):719-730.e14 PMID: 29398112 PMCID: PMC6309861 SCOPUS ID: 2-s2.0-85041554345 02/06/2018       170 Citations
  • Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor. (Che T, Majumdar S, Zaidi SA, Ondachi P, McCorvy JD, Wang S, Mosier PD, Uprety R, Vardy E, Krumm BE, Han GW, Lee MY, Pardon E, Steyaert J, Huang XP, Strachan RT, Tribo AR, Pasternak GW, Carroll FI, Stevens RC, Cherezov V, Katritch V, Wacker D, Roth BL) Cell 2018 Jan 11;172(1-2):55-67.e15 PMID: 29307491 PMCID: PMC5802374 SCOPUS ID: 2-s2.0-85039900111 01/09/2018       268 Citations
  • Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs. (McCorvy JD, Butler KV, Kelly B, Rechsteiner K, Karpiak J, Betz RM, Kormos BL, Shoichet BK, Dror RO, Jin J, Roth BL) Nat Chem Biol 2018 Feb;14(2):126-134 PMID: 29227473 PMCID: PMC5771956 SCOPUS ID: 2-s2.0-85040926100 12/12/2017       125 Citations
  • The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand. (Chan JD, Cupit PM, Gunaratne GS, McCorvy JD, Yang Y, Stoltz K, Webb TR, Dosa PI, Roth BL, Abagyan R, Cunningham C, Marchant JS) Nat Commun 2017 Dec 05;8(1):1910 PMID: 29208933 PMCID: PMC5716991 SCOPUS ID: 2-s2.0-85037138864 12/07/2017       56 Citations
  • D4 dopamine receptor high-resolution structures enable the discovery of selective agonists. (Wang S, Wacker D, Levit A, Che T, Betz RM, McCorvy JD, Venkatakrishnan AJ, Huang XP, Dror RO, Shoichet BK, Roth BL) Science 2017 Oct 20;358(6361):381-386 PMID: 29051383 PMCID: PMC5856174 SCOPUS ID: 2-s2.0-85032508115 10/21/2017       161 Citations
  • Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications. (Zhang G, Cheng J, McCorvy JD, Lorello PJ, Caldarone BJ, Roth BL, Kozikowski AP) J Med Chem 2017 Jul 27;60(14):6273-6288 PMID: 28657744 PMCID: PMC7374938 SCOPUS ID: 2-s2.0-85026350812 06/29/2017       19 Citations
  • Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775). (Brandt SD, Kavanagh PV, Twamley B, Westphal F, Elliott SP, Wallach J, Stratford A, Klein LM, McCorvy JD, Nichols DE, Halberstadt AL) Drug Test Anal 2018 Feb;10(2):310-322 PMID: 28585392 PMCID: PMC6230476 SCOPUS ID: 2-s2.0-85026419779 06/07/2017       40 Citations
  • Experimental evaluation of the generalized vibrational theory of G protein-coupled receptor activation. (Hoehn RD, Nichols DE, McCorvy JD, Neven H, Kais S) Proc Natl Acad Sci U S A 2017 May 30;114(22):5595-5600 PMID: 28500275 PMCID: PMC5465905 SCOPUS ID: 2-s2.0-85020029345 05/14/2017       14 Citations
  • Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of N-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2A Receptor Agonist. (Jensen AA, McCorvy JD, Leth-Petersen S, Bundgaard C, Liebscher G, Kenakin TP, Bräuner-Osborne H, Kehler J, Kristensen JL) J Pharmacol Exp Ther 2017 Jun;361(3):441-453 PMID: 28360333 SCOPUS ID: 2-s2.0-85019839785 04/01/2017       46 Citations
  • In silico design of novel probes for the atypical opioid receptor MRGPRX2. (Lansu K, Karpiak J, Liu J, Huang XP, McCorvy JD, Kroeze WK, Che T, Nagase H, Carroll FI, Jin J, Shoichet BK, Roth BL) Nat Chem Biol 2017 May;13(5):529-536 PMID: 28288109 PMCID: PMC5391270 SCOPUS ID: 2-s2.0-85015006304 03/14/2017       209 Citations
  • Crystal Structure of an LSD-Bound Human Serotonin Receptor. (Wacker D, Wang S, McCorvy JD, Betz RM, Venkatakrishnan AJ, Levit A, Lansu K, Schools ZL, Che T, Nichols DE, Shoichet BK, Dror RO, Roth BL) Cell 2017 Jan 26;168(3):377-389.e12 PMID: 28129538 PMCID: PMC5289311 SCOPUS ID: 2-s2.0-85010703450 01/28/2017       292 Citations
  • Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties. (Urs NM, Gee SM, Pack TF, McCorvy JD, Evron T, Snyder JC, Yang X, Rodriguiz RM, Borrelli E, Wetsel WC, Jin J, Roth BL, O'Donnell P, Caron MG) Proc Natl Acad Sci U S A 2016 Dec 13;113(50):E8178-E8186 PMID: 27911814 PMCID: PMC5167191 SCOPUS ID: 2-s2.0-85005965121 12/03/2016       104 Citations
  • Psilocybin for depression and anxiety associated with life-threatening illnesses. (McCorvy JD, Olsen RH, Roth BL) J Psychopharmacol 2016 Dec;30(12):1209-1210 PMID: 27909171 SCOPUS ID: 2-s2.0-85001129985 12/03/2016       11 Citations
  • Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists. (Chen X, McCorvy JD, Fischer MG, Butler KV, Shen Y, Roth BL, Jin J) J Med Chem 2016 Dec 08;59(23):10601-10618 PMID: 27805392 PMCID: PMC5148701 SCOPUS ID: 2-s2.0-85003632910 11/03/2016       45 Citations
  • Design and Discovery of Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists. (Cheng J, McCorvy JD, Giguere PM, Zhu H, Kenakin T, Roth BL, Kozikowski AP) J Med Chem 2016 Nov 10;59(21):9866-9880 PMID: 27726356 SCOPUS ID: 2-s2.0-84994823994 10/12/2016       26 Citations
  • Structure-based discovery of opioid analgesics with reduced side effects. (Manglik A, Lin H, Aryal DK, McCorvy JD, Dengler D, Corder G, Levit A, Kling RC, Bernat V, Hübner H, Huang XP, Sassano MF, Giguère PM, Löber S, Da Duan, Scherrer G, Kobilka BK, Gmeiner P, Roth BL, Shoichet BK) Nature 2016 Sep 08;537(7619):185-190 PMID: 27533032 PMCID: PMC5161585 SCOPUS ID: 2-s2.0-84984612101 08/18/2016       685 Citations
  • A Miniaturized Screen of a Schistosoma mansoni Serotonergic G Protein-Coupled Receptor Identifies Novel Classes of Parasite-Selective Inhibitors. (Chan JD, McCorvy JD, Acharya S, Johns ME, Day TA, Roth BL, Marchant JS) PLoS Pathog 2016 May;12(5):e1005651 PMID: 27187180 PMCID: PMC4871480 SCOPUS ID: 2-s2.0-84973334825 05/18/2016       30 Citations
  • In Vitro and In Vivo Characterization of the Alkaloid Nuciferine. (Farrell MS, McCorvy JD, Huang XP, Urban DJ, White KL, Giguere PM, Doak AK, Bernstein AI, Stout KA, Park SM, Rodriguiz RM, Gray BW, Hyatt WS, Norwood AP, Webster KA, Gannon BM, Miller GW, Porter JH, Shoichet BK, Fantegrossi WE, Wetsel WC, Roth BL) PLoS One 2016;11(3):e0150602 PMID: 26963248 PMCID: PMC4786259 SCOPUS ID: 2-s2.0-84962584770 03/11/2016       29 Citations
  • Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models. (Cheng J, Giguere PM, Schmerberg CM, Pogorelov VM, Rodriguiz RM, Huang XP, Zhu H, McCorvy JD, Wetsel WC, Roth BL, Kozikowski AP) J Med Chem 2016 Jan 28;59(2):578-91 PMID: 26704965 PMCID: PMC8317212 SCOPUS ID: 2-s2.0-84970916717 12/26/2015       23 Citations
  • PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. (Kroeze WK, Sassano MF, Huang XP, Lansu K, McCorvy JD, Giguère PM, Sciaky N, Roth BL) Nat Struct Mol Biol 2015 May;22(5):362-9 PMID: 25895059 PMCID: PMC4424118 SCOPUS ID: 2-s2.0-84929285245 04/22/2015       446 Citations
  • Structure and function of serotonin G protein-coupled receptors. (McCorvy JD, Roth BL) Pharmacol Ther 2015 Jun;150:129-42 PMID: 25601315 PMCID: PMC4414735 SCOPUS ID: 2-s2.0-84939959325 01/21/2015       243 Citations
  • Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists. (Hansen M, Jacobsen SE, Plunkett S, Liebscher GE, McCorvy JD, Bräuner-Osborne H, Kristensen JL) Bioorg Med Chem 2015 Jul 15;23(14):3933-7 PMID: 25583099 SCOPUS ID: 2-s2.0-84930872209 01/15/2015       22 Citations
  • Structural features for functional selectivity at serotonin receptors. (Wacker D, Wang C, Katritch V, Han GW, Huang XP, Vardy E, McCorvy JD, Jiang Y, Chu M, Siu FY, Liu W, Xu HE, Cherezov V, Roth BL, Stevens RC) Science 2013 May 03;340(6132):615-9 PMID: 23519215 PMCID: PMC3644390 SCOPUS ID: 2-s2.0-84877631485 03/23/2013       570 Citations
  • Structural basis for molecular recognition at serotonin receptors. (Wang C, Jiang Y, Ma J, Wu H, Wacker D, Katritch V, Han GW, Liu W, Huang XP, Vardy E, McCorvy JD, Gao X, Zhou XE, Melcher K, Zhang C, Bai F, Yang H, Yang L, Jiang H, Roth BL, Cherezov V, Stevens RC, Xu HE) Science 2013 May 03;340(6132):610-4 PMID: 23519210 PMCID: PMC3644373 SCOPUS ID: 2-s2.0-84877607189 03/23/2013       428 Citations
  • Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands. (Juncosa JI Jr, Hansen M, Bonner LA, Cueva JP, Maglathlin R, McCorvy JD, Marona-Lewicka D, Lill MA, Nichols DE) ACS Chem Neurosci 2013 Jan 16;4(1):96-109 PMID: 23336049 PMCID: PMC3547484 SCOPUS ID: 2-s2.0-84866414310 01/22/2013       46 Citations
  • trans-2-(2,5-Dimethoxy-4-iodophenyl)cyclopropylamine and trans-2-(2,5-dimethoxy-4-bromophenyl)cyclopropylamine as potent agonists for the 5-HT(2) receptor family. (Pigott A, Frescas S, McCorvy JD, Huang XP, Roth BL, Nichols DE) Beilstein J Org Chem 2012;8:1705-9 PMID: 23209503 PMCID: PMC3511003 SCOPUS ID: 2-s2.0-84867753861 12/05/2012       15 Citations
  • Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand. (Clark AH, McCorvy JD, Conley JM, Williams WK, Bekkam M, Watts VJ, Nichols DE) Bioorg Med Chem 2012 Nov 01;20(21):6366-74 PMID: 23018094 PMCID: PMC3505999 SCOPUS ID: 2-s2.0-84867577564 09/29/2012       9 Citations
  • Comparison of the D₁ dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease. (McCorvy JD, Watts VJ, Nichols DE) Psychopharmacology (Berl) 2012 Jul;222(1):81-7 PMID: 22222862 SCOPUS ID: 2-s2.0-84861840044 01/10/2012       7 Citations
  • Assessment of dopamine D₁ receptor affinity and efficacy of three tetracyclic conformationally-restricted analogs of SKF38393. (Clark AH, McCorvy JD, Watts VJ, Nichols DE) Bioorg Med Chem 2011 Sep 15;19(18):5420-31 PMID: 21862338 PMCID: PMC3171562 SCOPUS ID: 2-s2.0-80052587881 08/25/2011       9 Citations
  • A 5-HT(2C) receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference. (McCorvy JD, Harland AA, Maglathlin R, Nichols DE) Neurosci Lett 2011 Nov 07;505(1):10-3 PMID: 21827831 PMCID: PMC3213641 SCOPUS ID: 2-s2.0-82455167912 08/11/2011       7 Citations
  • C-Ring expanded analogs of doxanthrine: Conformation plays a critical role (Clark LH, Cueva JP, McCorvy JD, Harland AA, Watts VJ, Nichols DE) Arkivoc 29 January 2011;2010(4):125-138 SCOPUS ID: 2-s2.0-84866675458 01/29/2011    
  • Comparison of the enantiomers of (+/-)-doxanthrine, a high efficacy full dopamine D(1) receptor agonist, and a reversal of enantioselectivity at D(1) versus alpha(2C) adrenergic receptors. (Przybyla JA, Cueva JP, Chemel BR, Hsu KJ, Riese DJ 2nd, McCorvy JD, Chester JA, Nichols DE, Watts VJ) Eur Neuropsychopharmacol 2009 Feb;19(2):138-46 PMID: 19028082 PMCID: PMC2636714 SCOPUS ID: 2-s2.0-57749201143 11/26/2008       14 Citations
    • Last update: 04/02/2024